MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (decrease)
increase in cash
-$1,736,294
Accounts payable and
accrued liabilities
$1,139,840
Depreciation expense
$27,685
Stock-based compensation to
employees and consultants
$9,300
Net cash used in
operating activities
-$1,736,294
Canceled cashflow
$1,176,825
Net loss
-$2,198,991
Prepaid expenses and
other current assets
$714,128
Back
Back
Cash Flow
source: myfinsight.com
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)